Dear clients,

we would like to inform you about a temporarily incorrect status displayed on the NANDO website in relation to the notification of 3EC International a. s. (hereinafter referred to as “3EC”) as Notified Body NB 2265 under Regulation (EU) 2017/746 on in vitro diagnostic medical devices, during the period from 8 July 2026 to 16 July 2026.

During this period, NANDO due to a technical error on portal temporarily displayed information indicating that the notification of 3EC under Regulation (EU) 2017/746 had expired.

We would like to assure you that, according to the current NANDO record, the notification of 3EC as Notified Body NB 2265 under Regulation (EU) 2017/746 is valid. The current NANDO document states a last approval date of 16 July 2026 – WITHOUT INTERRUPTION.

The current scope of tasks and technical competences of 3EC is set out in the NANDO notification document – NB 2265 (last approval date: 16 July 2026).

The current NANDO record is also available through the following link: NANDO – Notified Body NB 2265, 3EC International a. s.

We are reviewing the circumstances of the temporarily incorrect status with the relevant authorities. We regret the uncertainty and any inconvenience this situation may have caused.

Should you have any questions or experience any specific complications related to this situation, please contact us at info@3ec.sk or michal.tomin@3ec.sk . We will address your enquiries as a priority.

Thank you for your understanding and cooperation.

3EC Team